Pasithea Therapeutics Corp. (KTTA)
NASDAQ·Healthcare·Biotechnology
$0.68
-1.06%
Mkt Cap $5.95M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | $100.00K | — | — | -$0.18 | -$0.89 | -394.44% | — | — |
| Q1 2026 Feb 25, 2026 | $200.00K | — | — | -$0.18 | -$0.18 | +0.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | — | -$0.41 | — | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | — | -$0.66 | — | — | — |
| Q2 2025 May 15, 2025 | — | — | — | — | -$1.61 | — | — | — |
| Q1 2025 Mar 24, 2025 | — | — | — | — | -$2.41 | — | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | — | -$2.87 | — | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | — | -$3.71 | — | — | — |
| Q2 2024 May 14, 2024 | — | — | — | — | -$3.70 | — | — | — |
| Q1 2024 Mar 28, 2024 | — | $976.31K | — | -$3.80 | -$4.85 | -27.54% | — | — |
| Q4 2023 Dec 29, 2023 | — | — | — | -$3.60 | -$2.87 | +20.23% | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | -$3.40 | -$2.88 | +15.28% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$3.40 | -$211.05 | -6107.32% | — | — |
| Q1 2023 Mar 30, 2023 | $300.00K | $240.71K | -19.76% | -$3.40 | -$3.00 | +11.86% | — | — |
| Q4 2022 Nov 14, 2022 | $200.00K | $218.61K | +9.30% | -$3.40 | -$3.45 | -1.61% | — | — |
| Q3 2022 Aug 15, 2022 | — | $13.58K | — | -$2.20 | -$0.08 | +96.48% | — | — |
| Q2 2022 May 16, 2022 | $300.00K | $13.66K | -95.45% | -$0.02 | -$0.07 | -250.00% | — | — |
| Q1 2022 Mar 30, 2022 | $100.00K | $15.06K | -84.94% | -$0.05 | $0.12 | +340.00% | — | — |
| Q4 2021 Nov 18, 2021 | — | — | — | — | -$0.17 | — | — | — |
| Q3 2021 Sep 16, 2021 | — | — | — | — | -$0.04 | — | — | — |